With the approval of Breo Ellipta in May 2013 and Anoro Ellipta in December 2013, formulary decision makers are faced with more treatment options for chronic obstructive pulmonary disease (COPD) than ever before. There are now three inhalers that are combination products of a long-acting beta agonist and a glucocorticoid that can potentially help patients with moderate to severe COPD. Research comparing these available therapeutic options is limited, making differentiation difficult. Despite that, let’s take a look at several notable differences among these drugs.
| Administration once daily | Administration twice daily | Black box warning | Approved for COPD | Approved for asthma | Recommended in GOLD guidelines for moderate–severe COPD | |
| Advair | • | • | • | • | • | |
| Breo Ellipta | • | • | • | |||
| Symbicort | • | • | • | • | ||
| Source: GOLD (Global Initiative for Chronic Obstructive Lung Disease) | ||||||
More like this
- Outcomes and Costs Associated With Initial Maintenance Therapy With Fluticasone Propionate-Salmeterol Xinafoate 250 μg/50 μg Combination Versus Tiotropium In Commercially Insured Patients With COPD
- Plans Breathe Life Into COPD Efforts
- COPD costs to approach $50B per year in 2020
- Outcomes Derail Study on Educated Consumers
- Ups and Downs at ASCO 2014
Our other journal
P&T Journal for September 2014
FEATURES
HEALTH CARE & LAW
Legal Risk Management Opportunities, Pharmacy Practice, and P&T Committees
Hospitals Struggle With ACA Challenges
Drug–Gene Interactions: Inherent Variability in Drug Maintenance Dose Requirements
Schizophrenia: Overview and Treatment Options
PIPELINE PLUS
Schizophrenia Therapy Options Increasing
DEPARTMENTS
MEDICATION ERRORS
Too Many Abandon the “Second Victims” of Medical Errors
PRESCRIPTION: WASHINGTON
New Controversy for 340B: OPA Rebuffs Ruling by Court
New Drugs/Drug News/New Medical Devices
Pharmaceutical Approval Update
DRUG FORECAST
Loxapine Inhalation Powder (Adasuve)
Paul Lendner ist ein praktizierender Experte im Bereich Gesundheit, Medizin und Fitness. Er schreibt bereits seit über 5 Jahren für das Managed Care Mag. Mit seinen Artikeln, die einen einzigartigen Expertenstatus nachweisen, liefert er unseren Lesern nicht nur Mehrwert, sondern auch Hilfestellung bei ihren Problemen.